Australia builds Nobel-prize science. We invest in the companies that carry it to market.
Pre-seed to Series A in Australian deep tech, with structural access into Greater China that no other Australian fund can match.
Building deep tech in Australia?
We back pre-seed to Series A deep-tech founders — bio & medical, advanced manufacturing, AI & robotics, climate & energy. ESVCLP-eligible, Australian-registered companies only.
Want exposure to top-decile Australian deep tech?
Newton Fund II is open to new wholesale investors. Eoarchean Fund I, our predecessor, sits in the top 10% of its 2021 vintage globally. 10% non-refundable ESVCLP tax offset.
Hello Clever 9.5× · Fiable 7× · Kite Magnetics 5×
See the portfolio →Six investments. Each anchored in defensible deep-tech IP. Multiples reported at fair value per IPEV guidelines, Q1 2026.
Australia has produced 15 Nobel laureates and runs world-class research institutions. Yet it has historically failed to capture the commercial upside — the science travels, the companies don't. The 2020–2027 window, with the A$15B National Reconstruction Fund and fewer than 12 active deep-tech VCs, is the entry point before valuations normalise. Our edge is in the technical due diligence that few Australian funds can run, and in the Greater China commercialisation corridor that no other Australian fund operates directly.
Read the full thesis →